🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joshua F. Zeidner

University of North Carolina at Chapel Hill

ORCID: 0000-0002-9014-1514

Also affiliated with UNC Lineberger Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia”.

Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

Journal of Clinical Investigation(2022)10.1172/jci159579
N/A
2.3DataRank · unranked
94 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +16 more

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

Annals of Hematology(2023)10.1007/s00277-023-05552-4
N/A
0.726DataRank · unranked
23 citations

Rory M. Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E. Roe +18 more

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091
N/A
0.216DataRank · unranked
3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756
N/A
0DataRank · unranked
50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity

Nature Cancer(2024)10.1038/s43018-024-00736-x
N/A
0DataRank · unranked
30 citations

Xin He, Lei Zhang, Wei Chen, Yi‐Chun Lin, Songbai Liu +27 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2
N/A
0DataRank · unranked
97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents

Cancer(2025)10.1002/cncr.35838
N/A
0DataRank · unranked
0 citations

Joshua F. Zeidner, D. Peters

Association of acute myeloid leukemias most immature phenotype with risk groups and outcomes

UNC Libraries(2020)10.17615/81j1-8w86
N/A
0DataRank · unranked
0 citations

B. Douglas Smith, Joshua F. Zeidner, Laura Morsberger, Sarah Morse, Hao Zhang +9 more

Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

medRxiv(2022)10.1101/2022.02.08.22270578
N/A
0DataRank · unranked
3 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +14 more